Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance
The DOI matches its Crossref record; 53 of the 54 references it cites were found in a registry or an index.
Abstract
Rationale Although psilocybin has been used for centuries for religious purposes, little is known scientifically about its acute and persisting effects. Objectives This double-blind study evaluated the acute and longer-term psychological effects of a high dose of psilocybin relative to a comparison compound administered under comfortable, supportive conditions. Materials and methods The participants were hallucinogen-naïve adults reporting regular participation in religious or spiritual activities. Two or three sessions were conducted at 2-month intervals. Thirty volunteers received orally administered psilocybin (30 mg/70 kg) and methylphenidate hydrochloride (40 mg/70 kg) in counterbalanced order. To obscure the study design, six additional volunteers received methylphenidate in the first two sessions and unblinded psilocybin in a third session. The 8-h sessions were conducted individually. Volunteers were encouraged to close their eyes and direct their attention inward. Study monitors rated volunteers' behavior during sessions. Volunteers completed questionnaires assessing drug effects and mystical experience immediately after and 2 months after sessions. Community observers rated changes in the volunteer's attitudes and behavior. Results Psilocybin produced a range of acute perceptual changes, subjective experiences, and labile moods including anxiety. Psilocybin also increased measures of mystical experience. At 2 months, the volunteers rated the psilocybin experience as…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The After the Spiritual Experience Questionnaire (ASEQ), developed by Harris and Gurel (2012) (Harris and Gurel, 2012), is partly based on the Persisting Effects Questionnaire (Griffiths et al., 2006). It contains 40 items, which load onto the following three subscales: Joy in Life, Relationship to the Sacred, and Toxic Feelings. We are not aware of any studies that examine the psychometric proper”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Griffiths et al., 2006
In the citing paper
“Psychedelic-assisted therapies currently offer one of the most robust experimental models for eliciting ST, frequently occasioning ego-dissolution and mystical-type experiences that are associated with sustained reductions in depression, anxiety, and addictive behaviors (97, 106).”
From The therapeutic role of self-transcendence in moral injury recovery: theory, mechanisms, and clinical implications (2026) · cites this paper as [97]
In the citing paper
“Nonetheless, the introspective and subjective experiences (i.e., significant changes in perception, cognition, affect, volition, and somesthesia) 16 induced by this compound may go beyond the dosage, pharmacokinetic, and pharmacodynamic mechanisms”
From The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges (2024) · cites this paper as [16]
In the citing paper
“Self-reported increases in interpersonal closeness and positive/altruistic social effects were reported 1, 2, 6, and 14 months after one and two administrations of psilocybin (89–92).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [89]
Citations
Cites
The PANAS-X: Manual for the Positive and Negative Affect Schedule - Expanded Form
Watson, D., & Clark, L. A. (1994) · University of Iowa · doi:10.17077/48vt-m4t2 · Cited by 3,700
Piedmont, R. L. (1999) · Journal of Personality · doi:10.1111/1467-6494.00080 · Cited by 1,172
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action
Vollenweider, F. X., Vollenweider-Scherpenhuyzen, M. F. I., Bäbler, A., Vogel, H., & Hell, D. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00024 · Cited by 1,018
Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1971122part1245 · Cited by 943
The Psychology of Religion: An Empirical Approach
Hall, C. M., Spilka, B., Hood, R. W., & Gorsuch, R. L. (1986) · Journal for the Scientific Study of Religion · doi:10.2307/1386305 · Cited by 943
Measurement and Mismeasurement of Mood: Recurrent and Emergent issues
Watson, D., & Clark, L. A. (1997) · Journal of Personality Assessment · doi:10.1207/s15327752jpa6802_4 · Cited by 717
The Psychology of Religion: An Empirical Approach
Hunsberger, B. E., Spilka, B., Hood, R. W., & Gorsuch, R. L. (1986) · Review of Religious Research · doi:10.2307/3511875 · Cited by 626
The Standardized Psychometric Assessment of Altered States of Consciousness (ASCs) in Humans
Dittrich, A. (1998) · Pharmacopsychiatry · doi:10.1055/s-2007-979351 · Cited by 577
(2024) · Thinking the Unknowable · doi:10.2307/jj.21341683.19 · Cited by 513
Strassman, R. J. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950020022002 · Cited by 453
Research works printed but not linked: 8
- Griffiths RR, Bigelow GE, Henningfield JE (1980) Similarities in animal and human drug-taking behavior. In: Mello NK (ed) Advances in substance abuse, vol 1. JAI, Greenwich, pp 1–90
- Metzner R (2004) Teonanacatl: sacred mushroom of visions. Four Tree, El Verano, CA
- Metzner R, Litwin G, Weil G (1965) The relation of expectation and mood to psilocybin reactions: a questionnaire study. Psychedelic Rev 5:3–39
- National Institute on Drug Abuse (2005) LSD NIDA infofacts. National Institute on Drug Abuse, Rockville, MD, February 2005
- Pahnke W (1963) Drugs and mysticism: an analysis of the relationship between psychedelic drugs and the mystical consciousness. Ph.D. thesis, Harvard University
- Presti DE, Nichols DE (2004) Biochemistry and neuropharmacology of psilocybin mushrooms. In: Metzner R, Darling DC (eds) Teonanacatl. Four Trees, El Verano, CA, pp 89–108
- Richards WA (1975) Counseling, peak experiences and the human encounter with death: an empirical study of the efficacy of DPT-assisted counseling in enhancing the quality of life of persons with terminal cancer and their closest family members. Ph.D. thesis, Catholic University of America, Washington, DC
- Stolaroff MJ (2001) A protocol for a sacramental service. In: Roberts TB (ed) Psychoactive sacramentals: essays on entheogens and religion. Council on Spiritual Practices, San Francisco, CA
Cited by
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201
“The structured interview (Community Observer Questionnaire) consisted of asking the rater to rate the participant’s behavior and attitudes using a 10-point scale (from 1 = not at all, to 10 = extremely) on 13 items reflecting healthy psychosocial functioning: inner peace; patience; good-natured humor/playfulness; ment…”
BackgroundMethodResultInfluentialSelf-citationNichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
“These experiences are often characterized as among the most meaningful of the subject’s life (e.g., see Griffiths et al., 2006) and can lead to persisting positive effects on attitudes, mood, and behavior.”
BackgroundMethodInfluentialRoss, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
“…transient near-psychotic symptoms) attributable to psilocybin are all known AEs of psilocybin, were transient, tolerable, and consistent with prior trials of psilocybin administration in normal volunteers (Griffiths et al., 2006, 2008, 2011), and patients with terminal cancer (Grob et al., 2011).”
BackgroundResultInfluentialEffects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial
Davis, A. K., Barrett, F. S., May, D. G., Cosimano, M. P., Sepeda, N. D., Johnson, M. W., Finan, P. H., & Griffiths, R. R. (2021) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2020.3285 · Cited by 1,301
Self-citationCarhart-Harris, R. L., Leech, R., Hellyer, P. J., Shanahan, M., Feilding, A., Tagliazucchi, E., Chialvo, D. R., & Nutt, D. (2014) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.00020 · Cited by 1,252
Metadata
- Authors
- Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Griffiths, R. R.
- Venue
- Psychopharmacology
- Published
- 2006-07-07
- Volume
- 187
- Issue
- 3
- Pages
- 268-283
- ISSN
- 0033-3158 (ISSN-L)
- 1432-2072
- OpenAlex
- W2121441663
- Semantic Scholar
- a938b18073aa78b06c799e700af70d9da680f750
- Cited by
- 1,684
- References
- 54
- Citations by year
- 2026: 111 · 2025: 214 · 2024: 202 · 2023: 189 · 2022: 168 · 2021: 150 · 2020: 100 · 2019: 74 · 2018: 70 · 2017: 66 · 2016: 64 · 2015: 37 · 2014: 45 · 2013: 34 · 2012: 46
- FWCI
- 25.48
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Psychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute on Drug Abuse (R01DA003889, R01DA03889)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Social Sciences › Psychology › Social Psychology › Paranormal Experiences and Beliefs
- Keywords
- psilocybin, mystical experience, spiritual meaning, personal meaning, long-term psychological effects, attitude and behavior change
- MeSH terms
- Adult, Affect, Blood Pressure, Double-Blind Method, Female, Hallucinogens, Heart Rate, Humans, Lysergic Acid Diethylamide, Male, Psilocybin, Surveys and Questionnaires, Cross-Over Studies, Substance-Related Disorders, Spirituality
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. https://app.cochat.ai/papers/10.1007/s00213-006-0457-5
- The paper
- Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology. https://doi.org/10.1007/s00213-006-0457-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.